Nasal chondromesenchymal hamartomas in a cohort with pathogenic germline variation in DICER1

Autor: Lauren M. Vasta, Alison Nichols, Laura A. Harney, Ana F. Best, Ann G. Carr, Anne K. Harris, Markku Miettinen, Kris Ann P. Schultz, Hung Jeffrey Kim, Douglas R. Stewart

Publikováno v: Rhinology Online, Vol 3, Pp 15-24 (2020)

Background: Nasal chondromesenchymal hamartomas are benign, rare nasal tumors associated with DICER1 pathogenic germ-line variation. They can be locally destructive and recurrent if not completely resected. Methodology: In this single-center, case-co

Externí odkaz: https://doaj.org/article/b172e575cdc8420aa3eaf0ef7dc0e837

Enrollment of adolescent and young adult patients newly diagnosed with cancer in NCI CTEP ‐sponsored clinical trials before and after launch of the NCI National Clinical Trials Network

Autor: Hari Sankaran, Shanda R. Finnigan, Lisa M. McShane, Ana F. Best, Nita L. Seibel

Publikováno v: Cancer. 128:3843-3849

Participation of adolescents and young adults (AYAs) in oncology clinical trials is important to ensure adequate opportunities for AYA patients to contribute to, and benefit from, advances in cancer treatment.Accrual data for National Cancer Institut

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6688421a62e854a31ed392a7af81775a
https://doi.org/10.1002/cncr.34402

Response to Song

Autor: Larissa A Korde, Ana F Best

Publikováno v: JNCI: Journal of the National Cancer Institute.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::188ef09295431c0005d3583a71bec8d2
https://doi.org/10.1093/jnci/djad054

Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0

Autor: Jane Perlmutter, Victoria S. Blinder, Laleh Amiri-Kordestani, Jared C. Foster, Eileen Rakovitch, Eric P. Winer, Angelo DiLeo, Julia White, Anthony D. Elias, Ana F. Best, Lynn Pearson Butler, Sara M. Tolaney, Lawrence Baizer, Patricia A. Spears, Elena Schwartz, David Cameron, Elizabeth Garrett-Mayer, Neelima Denduluri, Elizabeth S. Frank, Larissa A. Korde, E. Shelley Hwang, Nadine Tung, Judith M Bliss

Publikováno v: M Tolaney, S, Garrett-Mayer, E, White, J, S. Blinder, V, C. Foster, J, Amiri Kordestani, L, Hwang, S, M. Bliss, J, Rakovitch, E, Perlmutter, J, A. Spears, P, Frank, E, M. Tung, N, D. Elias, A, Cameron, D A, Denduluri, N, F. Best, A, Di Leo, A, Baizer, L, Pearson Butler, L, Schwartz, E, P Winer, E & A. Korde, L 2021, ' Updated standardized definitions for efficacy endpoints in adjuvant breast cancer clinical trials: STEEP Version 2.0 ', Journal of Clinical Oncology . https://doi.org/10.1200/JCO.20.03613
J Clin Oncol

PURPOSEThe Standardized Definitions for Efficacy End Points (STEEP) criteria, established in 2007, provide standardized definitions of adjuvant breast cancer clinical trial end points. Given the evolution of breast cancer clinical trials and improvem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::462fd891363195e2418ad331df8718fa
https://doi.org/10.1200/jco.20.03613

Geographic Inequalities in Cardiovascular Mortality in the United States: 1999 to 2018

Autor: Pankaj Arora, Ana F. Best, Vibhu Parcha, Sarabjeet S. Suri, Thomas J. Wang, Nirav Patel, Rajat Kalra, Garima Arora

Publikováno v: Mayo Clinic Proceedings. 96:1218-1228

Objective To evaluate the trends in cardiovascular, ischemic heart disease (IHD), stroke, and heart failure mortality in the stroke belt in comparison with the rest of the United States. Patients and Methods We evaluated the nationwide mortality data

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2680cacfab3493ce9f04a8ae6a572f6
https://doi.org/10.1016/j.mayocp.2020.08.036